We came across a bullish thesis on AbbVie Inc. on Dividend Talks’s Substack. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at $185.62 as of June 30th. ABBV’s trailing and forward P/E were 79.32 and 15.27 respectively according to Yahoo Finance.
A close-up of a biotechnology machine working on an oncology therapy.
AbbVie Inc. (ABBV), a global biopharmaceutical leader, specializes in advanced therapies targeting chronic and complex...
